Blood Pressure Drug Shows Promise for Migraine Relief

For millions of people living with migraines, even brushing their hair can trigger excruciating pain.

Now researchers at the University of Iowa have discovered that prazosin, a drug already approved for high blood pressure, might offer relief by helping the brain clear out migraine-causing chemicals. The team presented their findings at the Oxford Glymphatic and Brain Clearance Symposium in April.

Around 1 in 7 people worldwide experience migraines. These aren't just headaches. About 60% of migraine sufferers experience facial pain, pressure in their cheeks and forehead, and sensitivity so severe that light touch becomes unbearable.

Current treatments work for many people, but one-third of patients don't respond to available medications. Some endure days of debilitating pain that prevents them from completing everyday tasks.

The research team stumbled onto this discovery almost by accident. While studying traumatic brain injuries in mice, they noticed that prazosin seemed to help control mice that had migraines too.

Intrigued, the researchers gave one group of mice prazosin in their drinking water for six weeks, while another group received regular water. They then triggered migraines in all the mice using CGRP, a chemical known to drive migraine pain.

Half an hour later, the team gently touched the mice's foreheads with plastic filaments of varying thickness. The prazosin group could tolerate substantially thicker filaments without flinching. In fact, they acted similarly to mice that hadn't received the migraine-inducing chemical at all.

The secret appears to lie in the brain's glymphatic system, a waste disposal network that flushes out harmful chemicals. CGRP impairs this cleaning system, but prazosin reverses that damage and helps sweep away pain-causing molecules.

The Bright Side

What makes this discovery especially promising is that prazosin is already FDA-approved and widely used. Researchers don't need to spend years proving the drug is safe for humans because doctors already prescribe it daily.

"If it works in humans, that would be fantastic," says Valentina Mosienko at the University of Bristol, who wasn't involved in the research. "The drug is already in use, so we know it's safe."

The team now plans to test whether the same effects occur in people with migraines.

For the millions who've tried medication after medication without relief, this research opens a door to hope that wasn't there before.